T. Rowe Price Associates
MDT icon

T. Rowe Price Associates’s Medtronic MDT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$527M Sell
6,046,276
-4,012,859
-40% -$350M 0.06% 259
2025
Q1
$904M Buy
10,059,135
+3,017,849
+43% +$271M 0.11% 179
2024
Q4
$562M Buy
7,041,286
+105,263
+2% +$8.41M 0.06% 247
2024
Q3
$624M Sell
6,936,023
-46,392
-0.7% -$4.18M 0.07% 243
2024
Q2
$550M Sell
6,982,415
-7,932,672
-53% -$624M 0.07% 256
2024
Q1
$1.3B Sell
14,915,087
-483,213
-3% -$42.1M 0.16% 136
2023
Q4
$1.27B Sell
15,398,300
-2,444,569
-14% -$201M 0.17% 128
2023
Q3
$1.4B Buy
17,842,869
+1,277,027
+8% +$100M 0.2% 106
2023
Q2
$1.46B Buy
16,565,842
+6,302,067
+61% +$555M 0.2% 97
2023
Q1
$827M Sell
10,263,775
-305,452
-3% -$24.6M 0.12% 166
2022
Q4
$821M Sell
10,569,227
-1,403,394
-12% -$109M 0.13% 158
2022
Q3
$967M Buy
11,972,621
+538,836
+5% +$43.5M 0.16% 132
2022
Q2
$1.03B Sell
11,433,785
-7,844,168
-41% -$704M 0.13% 167
2022
Q1
$2.14B Sell
19,277,953
-6,704,178
-26% -$744M 0.22% 94
2021
Q4
$2.69B Buy
25,982,131
+2,284,638
+10% +$236M 0.24% 83
2021
Q3
$2.97B Buy
23,697,493
+1,005,075
+4% +$126M 0.28% 74
2021
Q2
$2.82B Buy
22,692,418
+735,134
+3% +$91.3M 0.26% 77
2021
Q1
$2.59B Buy
21,957,284
+1,417,008
+7% +$167M 0.26% 81
2020
Q4
$2.41B Buy
20,540,276
+2,880,467
+16% +$337M 0.25% 84
2020
Q3
$1.84B Buy
17,659,809
+1,868,006
+12% +$194M 0.21% 98
2020
Q2
$1.45B Sell
15,791,803
-591,813
-4% -$54.3M 0.18% 114
2020
Q1
$1.48B Sell
16,383,616
-2,805,876
-15% -$253M 0.23% 93
2019
Q4
$2.18B Sell
19,189,492
-3,544,487
-16% -$402M 0.28% 74
2019
Q3
$2.47B Buy
22,733,979
+522,803
+2% +$56.8M 0.35% 61
2019
Q2
$2.16B Buy
22,211,176
+516,915
+2% +$50.3M 0.3% 74
2019
Q1
$1.98B Sell
21,694,261
-1,657,949
-7% -$151M 0.29% 77
2018
Q4
$2.12B Buy
23,352,210
+105,611
+0.5% +$9.61M 0.36% 61
2018
Q3
$2.29B Sell
23,246,599
-830,133
-3% -$81.7M 0.33% 68
2018
Q2
$2.06B Buy
24,076,732
+2,139,822
+10% +$183M 0.32% 69
2018
Q1
$1.76B Sell
21,936,910
-2,292,251
-9% -$184M 0.28% 81
2017
Q4
$1.96B Sell
24,229,161
-788,884
-3% -$63.7M 0.32% 71
2017
Q3
$1.95B Buy
25,018,045
+961,217
+4% +$74.8M 0.33% 68
2017
Q2
$2.14B Sell
24,056,828
-1,074,264
-4% -$95.3M 0.38% 56
2017
Q1
$2.02B Buy
25,131,092
+2,694,221
+12% +$217M 0.38% 59
2016
Q4
$1.6B Buy
22,436,871
+747,203
+3% +$53.2M 0.32% 77
2016
Q3
$1.87B Sell
21,689,668
-313,014
-1% -$27M 0.38% 62
2016
Q2
$1.91B Sell
22,002,682
-22,197
-0.1% -$1.93M 0.4% 50
2016
Q1
$1.65B Sell
22,024,879
-464,166
-2% -$34.8M 0.35% 63
2015
Q4
$1.73B Sell
22,489,045
-151,716
-0.7% -$11.7M 0.36% 65
2015
Q3
$1.52B Buy
22,640,761
+1,023,895
+5% +$68.5M 0.34% 73
2015
Q2
$1.6B Buy
21,616,866
+2,001,530
+10% +$148M 0.33% 74
2015
Q1
$1.53B Buy
19,615,336
+11,453,179
+140% +$893M 0.32% 75
2014
Q4
$589M Buy
8,162,157
+5,959,711
+271% +$430M 0.13% 201
2014
Q3
$136M Sell
2,202,446
-36,309
-2% -$2.25M 0.03% 517
2014
Q2
$143M Buy
2,238,755
+38,401
+2% +$2.45M 0.03% 531
2014
Q1
$135M Buy
2,200,354
+65,897
+3% +$4.06M 0.03% 539
2013
Q4
$122M Buy
2,134,457
+61,235
+3% +$3.51M 0.03% 560
2013
Q3
$110M Sell
2,073,222
-36,647
-2% -$1.95M 0.03% 561
2013
Q2
$109M Buy
+2,109,869
New +$109M 0.03% 545